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Abstract
Background: We have previously shown that suspension culture prevents follicle flattening and maintains three-dimensional
follicle architecture better than culture on flat plates. However, many of the follicles cultured in suspension do eventually
rupture, as basement membrane integrity is lost and the three-dimensional structure of the follicle is altered. Therefore, the
objective of this study is to support three-dimensional follicle architecture during in vitro growth of ovarian follicles through
encapsulation in calcium alginate, while maintaining responsiveness to FSH stimulation.
Methods: Preantral follicles (150 – 160 micrometers in diameter) were isolated from the ovaries of juvenile rats and grown in
culture tubes or encapsulated in calcium alginate and grown in culture tubes. Previous studies revealed that follicles maintained
structural integrity but did not grow as well when encapsulated in calcium alginate. In these studies, we evaluated the effect of
calcium alginate on FSH-stimulated follicle growth, survival, and morphology in suspension culture. Follicles were grown under
5 culture conditions: 1) not encapsulated; with FSH in the medium, 2) encapsulated in the absence of FSH, grown in medium
without FSH, 3) encapsulated with calcium alginate containing FSH but grown in medium without FSH, 4) encapsulated without
FSH but grown in medium containing FSH and 5) encapsulated with calcium alginate containing FSH and in medium containing
FSH. To assess growth rates, follicles were cultured for 72 hours and analyzed for follicle size increase and DNA content.
Survival analysis for encapsulated and unencapsulated follicles was performed by constructing a Kaplan Meier survival curve of
daily observations of intact follicle survival. Three-dimensional architecture was assessed histologically and by analysis of the
pattern of connexin 43 expression in the cultured follicles.
Results: In the absence of FSH, follicle diameter increased by only 6.4%. When FSH was included in the alginate bead alone or
the media alone, the follicle diameter increased by 13.5% and 19.9% respectively. This was greater than follicles cultured in the
absence of FSH (p < 0.05), but less than that of the FSH-treated unencapsulated follicles (p < 0.05). However, when follicles
were cultured with FSH included in both the media and the bead, a 32.6% increase in follicle diameter was observed, statistically
no different than the growth rate of the unencapsulated follicles grown with FSH.
Conclusion: Microencapsulation supports three-dimensional follicle growth, but may limit access to hormones in the medium
resulting in altered development compared to unencapsulated follicles. Inclusion of FSH in the alginate bead restores the follicle
growth response to FSH, while also providing a scaffold of support for three-dimensional growth. The application of tissue
engineering principles to the problems of follicle culture in vitro may provide advances applicable to fertility preservation in
women and endangered species.
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Background
The culture of intact ovarian follicles is useful for the study
of the regulation of folliculogenesis, but may also provide
an alternative to ovarian transplant for the preservation of
fertility [1]. Classically, ovarian follicle culture has been
performed in culture dishes, on a flat surface. Although
ovarian follicles from the mouse can readily be grown on
culture plates [2,3], the maturation of follicles from larger
mammals has proven to be much more difficult [1]. One
cause of difficulty may be that larger follicles have differ-
ent structural needs. Mouse follicles can ovulate at 400
µm in diameter [4], whereas rat preovulatory follicles are
often greater than 800 µm in diameter [5]. Though this
represents only a doubling of diameter, the volume of the
rat preovulatory follicle is at least 8 times that of the
mouse. The application of standard tissue engineering
principles to the growth of ovarian follicles in vitro may
provide additional tools necessary to overcome the struc-
tural challenges presented by follicles from larger mam-
mals and make significant advances in this field.
It has been shown that suspension culture both enhances
cell proliferation [6] and prevents follicle flattening and
maintains three-dimensional follicle architecture better
than culture on flat plates [7]. Though mouse follicles
grown in a hanging drop system grew very well compared
to follicles grown on flat plates, the follicle diameter was
still well under 500 after 6 days of culture [6]. Rat follicles
often rupture at 200 to 250 µm on flat plates. However in
suspension culture follicles routinely maintain intact sur-
vival to about 400 µm. Past this size, basement membrane
integrity is lost and the three-dimensional structure of the
follicle is altered. One tissue engineering approach to this
problem is to encapsulate the follicles. Microencapsula-
tion has been used to provide structural support for a vari-
ety of tissues such as pancreatic islets [8] and thyroid
follicles [9].
Alginate is one of the most commonly applied biomateri-
als for microencapsulation due to its biocompatibility,
high affinity to water, and ability to form gels under mild
conditions when in the presence of calcium ions [10-14].
Alginate is comprised of chains of alternating blocks of
mannuronic acid, which contributes the elastic property
of the gel; and guluronic acid, which contributes mechan-
ical strength, stability, porosity, and gel forming proper-
ties [15,16]. Alginates are extracted from all species of
brown algae and contain differing compositions of man-
nuronic acid/mannuronic acid, mannuronic acid/glu-
coronic acid, and glucoronic acid/glucoronic acid blocks
offering a variation in strength and stability. Alginate gel
beads are reported to have a high porosity range and only
limit the diffusion of large proteins [12]. It has been
reported that substrates of molecular weight less than 2 ×
104, such as glucose, L-tryptophan (MW = 204), and α-lac-
toalbumin (MW = 1.54 × 104), are able to diffuse freely
into and from calcium alginate beads at approximately
the same diffusion rate as in water, while larger proteins,
such as albumin (MW = 6.9 × 104), could not diffuse
freely into the calcium alginate beads [17]. Although there
is resistance for larger proteins (MW > 2 × 104) diffusing
into these beads, diffusion from the bead into a surround-
ing solution devoid of the substrate is not hindered until
the molecular weight of the substrate approaches 3 × 105
[11]. FSH has a molecular weight of 3 × 104 [18]. Thus,
FSH is in the size range where hindrance may play a role
in FSH availability to follicles encapsulated in calcium
alginate beads.
In this study, the role of a calcium alginate scaffold on fol-
licle growth, survival, and morphology in suspension cul-
ture was explored. Our previous studies suggested that
alginate encapsulation slowed follicle growth [7]. There-
fore, in these studies we have determined the growth rates
of follicles in response to different delivery methods of
FSH to encapsulated follicles. As a result, we have estab-
lished the ability of calcium alginate to support three-
dimensional follicular growth of intact follicles, but dis-
covered that encapsulation may limit follicular access to
FSH unless it is included in the alginate bead itself.
Materials and methods
Animals and Ovarian Dissection
All animal experiments were performed in accordance
with National Institutes of Health guidelines and with
institutional approval. Sprague-Dawley rats were
obtained from Hilltop Lab Animals (Pittsburgh, PA) and
housed under standard conditions. The animals were sac-
rificed by CO2 exposure and cervical dislocation. Ovaries
were carefully dissected and placed immediately in
warmed culture medium, consisting of Leibovitz L-15
Medium (Gibco BRL) with 1% bovine serum albumin
(Sigma). The follicles were then mechanically dissected
from the ovary as previously described [19]. All follicles
used in the experiments were measured in two dimen-
sions, using an inverted microscope fitted with an ocular
micrometer. Only intact follicles that were between 150
and 160 microns in diameter were used in culture. There
was no statistical difference in the starting follicle diame-
ter of any of the groups.
Calcium Alginate Microencapsulation
After dissection, 20 to 30 follicles per group were trans-
ferred with glass pipettes to a solution of sodium alginate
(1% w/v; Sigma) in distilled water. (For the groups that
required FSH in the bead, follicles were transferred to a
solution of sodium alginate containing recombinant Fol-
licle Stimulating Hormone, rFSH, (Serono Laboratories,
Geneva) at a concentration of 1 iu/mL.) The mixture of
follicles in sodium alginate was slowly released through aReproductive Biology and Endocrinology 2005, 3:47 http://www.rbej.com/content/3/1/47
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25-gauge needle as droplets falling into a beaker contain-
ing a stirred solution of CaCl2 (0.1 M). The droplets
immediately gelled to form beads. A stream of 0.2 µm-fil-
tered air was positioned at the tip of the needle to cut the
mixture stream into small droplets to obtain beads with
diameters between 250 µm to 400 µm. Beads containing
individual follicles (Figure 1) were then removed from the
beaker using glass pipettes and immediately transferred to
media in 12 × 75 mm polypropylene culture tubes. Folli-
cles were cultured one per tube.
Follicle Culture
Culture media consisted of α-Minimal Essential Medium
(Gibco BRL, Invitrogen Corporation, Grand Island, NY)
with additives of 8-bromo-cGMP (5 mM), ITS+ (1 % solu-
tion of insulin, 10 mg/L; transferrin, 5.5 mg/L; linoleic
acid, 4.7 mg/L; selenium, 5 mg/L), Pen/Strep (1 %, peni-
cillin 100 U/ml, streptomycin 100 µg/ml), all from Sigma
Chemical Co. (St. Louis, MO), and recombinant Follicle
Stimulating Hormone, rFSH, (1 iu/ml; Serono Laborato-
ries, Geneva). In the basal or negative control group, FSH
was not included. Culture media was placed into 12 × 75
mm polypropylene culture test tubes (500 µl/tube) and
cultured in 5 % CO2 and 37°C humidified incubator.
Suspension was attained by placing the 12 × 75 mm poly-
propylene culture tubes in a circular rotator plate (Glas-
Col, Terre Haute, IN), having a diameter of 30.5 cm,
which was rotated around its horizontal axis at rate
between 8–15 rpm. Therefore, as the plate rotates, the
tubes slowly orbit the axis of the plate and the follicle is
maintained is fluid suspension. After 72 hours in culture,
follicle diameter was measured once again and follicles
were collected for DNA quantification and histological
analysis. For survival analysis, follicles were observed
daily for basement membrane integrity and signs of
atresia. Atresia is readily apparent as darkening of the fol-
licle appearance under the dissecting microscope [7,20].
Survival analysis cultures were continued for 7 days.
DNA Quantification
To verify that increased follicle size represented increased
follicle cell number, DNA quantification was performed
on the cultured follicles as previously described [7]. At 72
hours of culture, the follicles were released from the beads
by allowing the capsules to dissolve in sterile PBS (pH
7.4). Follicles (n = 5 for each group) were then trypsinized
and DNA was extracted from each individual follicle and
quantified by using the fluorescent dye, Hoechst 33258
(bisbenzimidazole; Sigma), and a microplate fluores-
cence reader (Perkin Elmer Life Sciences, Boston, MA) at
365 nm excitation and 450 nm emission wavelengths
[21]. A range of known dilutions of salmon testes DNA
(Sigma) was used to plot a standard curve from which fol-
licle DNA content was extrapolated as previously
described [7]. This experiment was repeated twice with the
same result.
Histology and Immunohistochemistry
To confirm that cultured follicles encapsulated in calcium
alginate retain normal anatomic relationships between
the cell types within a follicle, immunohistochemistry for
connexin 43 was performed on follicles that were cultured
in calcium alginate beads with and without FSH. Some
additional sections were also stained with hematoxylin
and eosin. At 72 hours of culture, the follicles were
released from the beads by allowing the capsules to dis-
solve in sterile PBS (pH 7.4). Follicles were embedded in
OCT for fluorescent immunostaining.
Frozen sections were cut at 5 µm and air-dried overnight
at room temperature. Sections from at least 10 follicles per
group were evaluated for connexin staining pattern. After
a 10 minute acetone fixation, slides were again allowed to
air dry, and then were rehydrated in PBS for 10 minutes.
Immunohistochemistry was performed using the M.O.M.
immunodetection system (Vector Laboratories, Burlin-
game, Calif.). All reagents were prepared according to kit
directions and all steps were carried out at room tempera-
ture. Slides were incubated with blocking reagent for 1
hour. Mouse anticonnexin (Chemicon International,
Temecula, CA) was prepared in diluent to a final concen-
tration of 0.1 µg/mL and applied to the sections for 1 hour
Ovarian Follicle Encapsulated in a Calcium Alginate Bead Figure 1
Ovarian Follicle Encapsulated in a Calcium Alginate Bead. 
Scale bar represents 50 µm.Reproductive Biology and Endocrinology 2005, 3:47 http://www.rbej.com/content/3/1/47
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in a humidified chamber. For negative control sections,
mouse IgG was substituted for the anti-connexin anti-
body. After a PBS wash, sections were incubated with
biotinylated anti-mouse IgG for 10 minutes. Slides were
again washed for 10 minutes in PBS, and then incubated
with fluorescein avidin DCS (1:62.5 in PBS) for 5 min-
utes. After a final 10 minute PBS wash, slides were
mounted with Vectashield mounting medium (Vector
Laboratories) and digitally imaged using a Leica CMR flu-
orescence microscope.
Statistical analysis
Statistical analysis for DNA quantification and follicle
diameters was performed by analysis of variance
(ANOVA) with post hoc testing. Survival data was ana-
lyzed with the Kaplan Meier program contained in the
Sigma Stat 3.0 software package (Chicago, Il). Probability
values less than 0.05 were used to determine significance.
Results
Effect of calcium alginate encapsulation and FSH 
treatments on follicle diameter
Average follicle diameters at the beginning and end of the
72-hour culture period are depicted in Figure 2A. To deter-
mine the effects of alginate alone, follicles were encapsu-
lated in calcium alginate, but grown in the complete
absence of FSH as a negative control. A positive control
comparison group consisted of follicles grown in the
standard fashion and treated with FSH, but without
encapsulation [7]. As expected, the negative control group
of follicles encapsulated and grown in the absence of FSH,
experienced minimal growth (diameter increase; 6.3%).
The positive control group of unencapsulated follicles
with FSH in the medium experienced a 35.4% increase in
diameter, consistent with our previous studies [7]. When
encapsulated follicles were grown in medium containing
FSH, a 19.9% increase in follicle diameter over the 72-
(A) Diameter of follicles cultured under different conditions over 72 h Figure 2
(A) Diameter of follicles cultured under different conditions over 72 h. Each line represents measured follicle diameter before 
and after 72 h of culture (n = 20 – 30 follicles per group). Data points are average diameter with standard error bars included 
for each treatment. Treatment conditions are listed to the right of the data point representing average diameter at 72 hours 
for each group. a, b, c represent statistically different groups (p < 0.05). (B) Kaplan Meier Survival Plot. Mean survival time for 
unencapsulated follicles is 4.5 days while mean survival time for encapsulated follicles is 6 days (p < 0.05).
ABReproductive Biology and Endocrinology 2005, 3:47 http://www.rbej.com/content/3/1/47
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hour culture period was observed (p < 0.05 relative to the
negative control). When FSH was included in the calcium
alginate capsule but not the medium, a 13.5% increase in
follicle diameter was observed. This was different from the
negative control (p < 0.05), but not the previously
described FSH in medium group (p > 0.05). However,
when follicles were cultured with FSH included in both
the medium and the bead, a 32.6% increase in follicle size
was observed.
The size of positive control follicles and encapsulated fol-
licles with FSH placed in the medium and the bead were
significantly different than the other three treatment
groups (Figure 2A, p < 0.05). Furthermore, there was no
significant difference between the growth of unencapsu-
lated FSH-treated cultures and the encapsulated follicles
with FSH present in both the bead and the medium (pos-
itive control, 54.3 ± 10.1 µm; FSH in bead and media,
49.2 ± 6.8 µm; p > 0.05).
Survival Analysis
The effect of encapsulation on follicle survival was evalu-
ated by Kaplan Meier analysis of daily observation of cul-
tured follicles. Survival plots for unencapsulated and
encapsulated FSH-treated follicles are shown in Figure 2B.
Mean intact survival time for encapsulated follicles, 6
days, was greater than the mean intact survival time for
unencapsulated follicles, 4.5 days (p < 0.05).
DNA Quantification confirms follicle growth
DNA content of individual follicles was consistent with
measured follicle size. The unencapsulated follicles in
FSH supplemented media (Positive Control) contained
50.7 ± 19.9 ng of DNA after 72 hours of culture. The
encapsulated follicles with FSH present in the media and
the bead (Experimental Group) contained 53.9 ± 15.9 ng
of DNA, not significantly different from the positive con-
trol. Both FSH-treated groups contained significantly
greater amounts of DNA than the encapsulated follicles
cultured in the absence of FSH (Negative Control) which
had only 27.8 ± 11.7 ng of DNA (p < 0.05).
Connexin 43 expression in cultured follicles
As seen in Figure 3A, connexin expression (green stain) is
very low in follicles in the absence of FSH. In the presence
of FSH, connexin expression is readily apparent in the
unencapsulated follicle (Figure 3C). However when the
follicle is encapsulated and treated with optimal FSH
(both in the alginate and in the medium), excellent
expression of connexin 43 is seen throughout the cross
section of the follicle (Figure 3E). This pattern is very sim-
ilar to the follicle grown in vivo (Figure 3G). The negative
control pictured (Figure 3H) is a serial section from the
same follicle from 3E and demonstrates that there is min-
imal background staining in this system. Follicle sections
stained with H&E are adjacent to the corresponding con-
nexin photograph. In the absence of FSH (Figure 3B), the
follicle remains intact but the granulosa cell layer is poorly
organized and contains numerous pyknotic appearing
cells. Figure 3D is of an FSH treated follicle that was not
encapsulated. There is a thickened appearance of the outer
granulosa cells though the cells around the oocyte appear
fairly normal. This is consistent with the area that stains
more heavily for connexin. Figure 3F depicts a typical fol-
licle grown in the bead with optimal FSH. There is good
morphology with a fairly uniform granulosa layer and a
healthy appearing oocyte.
Discussion
In this study, we have demonstrated that calcium alginate
encapsulation can act as a scaffold to support three-
dimensional relationships between the cells of a follicle in
suspension culture. However we have also demonstrated
that calcium alginate encapsulation can impede access of
the follicle to FSH in the medium.
We have previously shown that FSH is a growth factor for
preantral follicles in culture [19]. Other investigators have
shown that the dosing and timing of follicle exposure to
FSH has threshold limits for continued growth and sur-
vival of mouse follicles [21]. Our previous work has dem-
onstrated that encapsulation slowed the rate of follicle
growth [7]. There were two hypotheses considered to
explain the decreased growth response to FSH. Either FSH
diffusion into the alginate bead was significantly limited,
or the bead itself physically hindered the growth of the
follicle.
With FSH present only in the bead, a concentration gradi-
ent is created between the bead and the media. Naturally
this gradient would drive the flux of FSH out of the cal-
cium alginate capsule. For this case, because the molecular
weight is less than 3 × 105, the FSH will freely diffuse out
of the bead until equilibrium is reached [17]. For a sub-
strate with the molecular weight of FSH, equilibrium
would be reached within 3 to 5 hours [11], resulting in a
much lower concentration of FSH within the bead for the
bulk of the 72 hour culture. As a result, follicular growth
response was greatly diminished compared to the positive
control (Figure 2).
Similarly, by adding FSH to only the media, a concentra-
tion gradient is established in the opposite direction, driv-
ing the flux of FSH from the media into the bead.
However, due to the molecular weight of the hormone
being greater than 2 × 104, the diffusion into the capsule
will be impeded [11]. The question is then, will the
decreased diffusion rate into the calcium alginate bead be
significant enough to cause the observed reduction in fol-
licular growth (Figure 2).Reproductive Biology and Endocrinology 2005, 3:47 http://www.rbej.com/content/3/1/47
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Connexin 43 expression and histology of representative cultured follicles Figure 3
Connexin 43 expression and histology of representative cultured follicles. (A and B) Encapsulated follicle in the absence of FSH, 
(C and D) Unencapsulated follicle grown in FSH supplemented media, (E and F) Encapsulated follicle with FSH present in both 
the media and the bead, (G) Connexin staining in preantral follicle of an intact ovary section. (H) Negative control for the 
immunohistochemical staining, serial section from the same follicle as in C. A, C, E, G, H, represent connexin immunohisto-
chemistry. B, D, and F are H&E stained follicle sections. In panel C, white line is location of basement membrane. Scale bars 
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To answer this, equal concentrations of FSH were placed
in both the bead and the culture media. By eliminating
the concentration gradients, FSH was not driven from the
bead, leaving the concentration of FSH within the bead
comparable to that present for the positive control. There-
fore, because the addition of FSH to the alginate bead
restored the follicular growth rate to that of the positive
control, the likely cause of the diminution of follicle
growth in our earlier studies [7] is a limitation of follicle
access to FSH by the encapsulation process.
In order to confirm appropriate cell-cell interactions
within the follicle, we next evaluated the expression of the
gap junction protein connexin 43 in cultured follicles.
Connexin 43 plays a key role in follicle development by
promoting communication between granulosa cells via
the exchange of small ions and molecules [22,23]. Con-
nexin 43 deficient mice have severely impaired follicle
development beyond the primary stage [24]. The expres-
sion and localization of connexin 43 is also highly FSH
dependant [22]. The evaluation of connexin in our cul-
tured follicles provides both a structural and a hormonal
assessment of the effect of alginate on follicle develop-
ment and FSH-stimulated differentiation.
In this study, it was found that the patterned expression of
connexin 43 is not affected by calcium alginate encapsu-
lation when the FSH is included in both the bead and the
medium (Figure 3). Encapsulated preantral follicles cul-
tured with FSH, maintain a well developed theca, a base-
ment membrane, a normally configured granulosa
compartment and a healthy appearing egg with a zona
pellucida (Figure 3E and 3F). Interestingly, it was
observed that the positive control lacked the punctuate
staining at its periphery (Figure 3C), while the encapsu-
lated follicle demonstrated consistent punctuate staining
throughout the entire granulosa layer (Figure 3E) similar
to in vivo preantral follicles (Figure 3G). This may suggest
that encapsulating the follicle might protect it from possi-
ble deleterious shearing forces in the suspension culture
system, since shear stress has been shown to affect con-
nexin expression [25]. Further studies will be needed to
more fully evaluate this phenomenon.
Although a variety of gels and scaffolds exist, calcium algi-
nate has some desired advantages. Unlike collagen based
gels [26,27], the follicle can be easily viewed through the
calcium alginate capsule, allowing for daily observations
to be made. Alginate is easily washed away with PBS,
unlike collagen. The alginate also does not seem to inter-
act with the follicles unless ECM or its components are
included in the gel [28]. Matrigel has also been used as an
imbedding medium for follicles. However matrigel is like
serum in that it is derived from undefined biological
sources and can have considerable content variation from
lot to lot. In contrast, calcium alginate is a well-defined gel
and fits with the goal of establishing a completely defined
culture system that can be stably reproduced and still meet
all the nutritional and structural needs of the developing
follicle.
Conclusion
These combined findings have demonstrated that micro-
encapsulation can improve the support of three dimen-
sional growth of preantral follicles; but requires the
inclusion of FSH in the scaffold. Further work is necessary
to determine if intact follicles can be maintained for
longer periods in culture with this scaffolding approach.
However, care must be taken to determine if the scaffold-
ing material itself alters the microfollicular environment.
Though follicle development is a prolonged and complex
process, careful application of tissue engineering princi-
ples may facilitate the eventual development of a consist-
ent, standardized in vitro process for follicle growth of
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